Fox funding moves Affiris' pioneering Parkinson's vaccine into the clinic
This article was originally published in Scrip
Executive Summary
The Michael J Fox Foundation has awarded $1.5 million to Affiris to support the first clinical study with Affitope PD01, the Austrian company's candidate peptide vaccine against Parkinson's disease.